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Abstract—  Human  umbilical  veins  (HUV)  have  recently 
been  suggested  as  a  starting  material  for  vascular  tissue 
engineering.  HUV possess  a  functional  smooth  muscle  layer 
and could be turned into an immunologically inert graft with 
contractile properties by creating a neoendothelium from the 
recipient's  own  cells.  This  study  investigated  methods  to 
remove  the  native  endothelium  without  impairing  the 
contractile function of the smooth muscle layer. These denuded 
HUV were then seeded with endothelial  cells  in a perfusion 
bioreactor, demonstrating the creation of a confluent,  shear-
resistant neoendothelium.
Keywords— vascular tissue engineering,  endothelium, human 
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INTRODUCTION 
Coronary artery disease is one of the most common mal­
adies in western societies. Coronary artery bypass grafting 
with  autologous  vessels  like  internal  mammary  artery, 
saphenous vein, and radial artery has evolved into a routine 
procedure  with  satisfactory  long-term  results.  However, 
there is a significant number of patients who cannot benefit 
from this procedure as they lack suitable autologous vessels 
as a consequence of varicosis, prior removal, or trauma.
Vessel  grafts  are  supposed  to  match  the  size  and  the 
compliance of the host vessels. Synthetic materials have not 
met the expectations for small-caliber grafts due to compli­
ance mismatches, infections, and thrombogenicity [1]. Bio­
logical scaffolds, especially those derived from vascular tis­
sue, provide an excellent starting point for tissue-engineered 
small caliber vessel grafts. These scaffolds are obtained by 
removing existing cells by mechanical or chemical methods. 
Their biological surfaces promote vascular cell adhesion as 
they mostly  consist  of  extracellular  matrix.  One potential 
problem is the immunogenicity of allogeneic or xenogeneic 
scaffolds even after decellularization.
Although  glutaraldehyde-fixed  human  umbilical  veins 
(HUV) have been used as grafts for peripheral reconstruc­
tions for decades [2], native HUV have been introduced as a 
starting  material  for  vascular  tissue  engineering  only  re­
cently. Daniel et al. used decellularized HUV [3], whereas 
our group suggested to keep the smooth muscle layer intact 
by using denuded HUV (denHUV) [4]. The immune proper­
ties of umbilical cord tissue are likely to permit allogeneic 
transplantation  which  was  shown  recently  for  umbilical 
cord stromal cells [5]. HUV were found to contract to sero­
tonin and to U46619, to possess a biphasic stress-strain rela­
tionship [6], to retain part of the contractile function and of 
tissue viability after cryopreservation, and to release the an­
tithrombotic agent prostacyclin even after denuding. Vascu­
lar function and antithrombotic properties were best in HUV 
from cesarean sections [7].
Although vascular grafts are supposed to carry endotheli­
al cells harvested from the recipient, HUV endothelial cells 
(HUVEC) are a commonly used model in the design stage. 
Seeding of HUVEC onto denHUV has so far been demon­
strated only on small, mechanically denuded patches under 
static  conditions  [6].  The  current  study identifies  suitable 
methods to denude longer segments of HUV and to seed en­
dothelial cells onto denHUV in a perfusion bioreactor.
MATERIALS AND METHODS
Harvesting of umbilical cords
Human umbilical cords from term or near-term pregnan­
cies were stored in Krebs-Henseleit buffer as described pre­
viously [4]. Veins were dissected free from Wharton's Jelly 
and rinsed with phosphate-buffered saline.
Denuding Methods
HUV segments of  6-8cm length were subjected to vari­
ous  denuding  methods.  Enzymatic  denudation  was  per­
formed according to a standard method of HUVEC isolation 
[8]  using  a  collagenase  (0.1%)  incubation  of  20  min  at 
37°C. Denudation by osmotic lysis was induced by perfus­
ing HUV with distilled water for various times. Denudation 
by dehydration was performed by flushing HUV with car­
bogen (95% oxygen, 5% carbon dioxide) at 60ml/min while 
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[9]. After all denudation procedures the vessels were rinsed 
liberally  with  phosphate-buffered  saline  to  protect  the 
smooth muscle layer and to remove endothelial cell debris. 
In  some experiments, HUV denuded by dehydration were 
filled with bovine gelatine (0.25%), incubated for 30 min at 
37°C, and rinsed again. denHUV segments were then ana­
lyzed in an organ bath and by microscopy.
Histology and scanning electron microscopy (SEM)
Samples of denuded or seeded HUV were fixed in 4% 
formaldehyde  and  embedded  in  paraffin.  Thin  sections 
were stained by hematoxylin and eosin for bright field mi­
croscopy  or  stained  with  DAPI  for  fluorescence  micro­
scopy. Endothelial integrity was assessed visually by trained 
personnel. Samples for scanning electron microscopy were 
fixed in 2% formaldehyde and 2.5% glutardialdehyde,  de­
hydrated, and sputtered with gold.
Contractile properties
Contractile functions of vessels were determined isomet­
rically in an organ bath as described previously [4]. Maxim­
um contractions caused by depolarization were determined 
by adding 150 mM KCl to the baths.
Perfusion bioreactor
denHUV were mounted in vessel chambers and attached 
to  custom-built  perfusion  bioreactors  operated  at  37°C. 
Each  circulation  consisted  of  medium  reservoir,  hollow 
fiber oxygenator (20% O2, 5% CO2), perfusion and superfu­
sion circuit pump hoses, and compliance chambers. Perfu­
sion  and  superfusion  circuits  were  driven  by  peristaltic 
pumps at 10 ml/min and 20 ml/min, respectively.  Ports at 
the vessel chamber inlets allowed to infuse cell suspensions 
for  seeding.  M199  with  Earle's  salts,  supplemented  with 
20% fetal calf serum, penicillin, streptomycin, amphotericin 
B, and gentamicin was used as culture medium.
Seeding procedure
HUVEC were  obtained from HUV as  described  previ­
ously [4]. They were labelled with Ulex europaeus agglutin­
in (UEA) covalently linked to the fluorescent marker FITC. 
Cells were detached using trypsin/EDTA and resuspended 
in culture medium. Perfusion was stopped whereas superfu­
sion continued to run, and cells were infused manually into 
the denHUV segments at a density of 4.5E5 cells/cm2. The 
vessel chambers were rotated every other min for 10 min 
and every 5 min for another 50 min to enforce even seeding. 
At 60, 75, 90, and 105 min perfusion was turned on again 
briefly at 10 ml/min. Starting at 120 min post seeding, the 
vessels  were  perfused at  10 ml/min for  another 120 min. 
Vessels were then fixed and analyzed by UV microscopy 
and SEM.
RESULTS
Denudation
Denudation  by osmotic  lysis  successfully  removed  the 
endothelium if the incubation lasted 5 min or longer (Fig. 1 
D-F). However, incubations of 3 min or longer significantly 
impaired contractions induced by KCl (Fig. 2).
Enzymatic treatment was also effective in removing the 
endothelium (Fig. 1 B). Microscopic analysis revealed ex­
tensive structural damage in the smooth muscle layer. Ves­
sels treated with collagenase responded to KCl significantly 
weaker (Fig. 2).
Denudation by dehydration completely removed the en­
dothelium (Fig. 1 C) without affecting contractile function 
(Fig. 3). Gelatine coating did not affect contractility of nat­
ive  HUV  or  of  HUV  denuded  by  dehydration  (p=0.494, 
ANOVA).
Seeding
Based on the results of the denudation experiments, only 
dehydration  was  used  to  denude  vessels  for  seeding.  As 
gelatine  coating  had  no negative  functional  effects,  some 
seeding experiments were done using gelatine coated den­
HUV.
Seeding with UEA-labelled HUVEC restored a confluent 
endothelium on denHUV. The en face SEM images show a 
smooth surface of the neoendothelium (Fig. 4 C). The cells 
appear larger but flatter compared to the native endotheli­
um.  The  histological  image  of  the  cross  section  demon­
strates  by  means  of  the  fluorescence  signal  that  the  en­
dothelial  cells  are indeed seeded cells  (Fig.  4 D).  Gelatin 
coating of denHUV had no visible effects on the seeding 
results (not shown).
DISCUSSION
This study compared denudation methods for HUV and 
demonstrated the seeding of a confluent neoendothelium on 
denuded HUV.
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3Fig 1: Cross sections of HUV stained with hematoxylin and eosin. (A) 
untreated control. (B) enzymatic denudation. (C) denuded by dehydration. 
(D-F) denudation by osmotic lysis for 1, 3, and 5 min, respectively. Bar 
indicates 50 µm.
Fig 2: Contraction of HUV denuded by osmotic lysis. Vessels were 
challenged with 150 mM KCl. Values are reported relative to untreated 
HUV (** p<0.01, ANOVA)
As mentioned previously, one goal of this project was to 
reuse the existing smooth muscle layer of HUV to build the 
vessel  walls of small  caliber  grafts.  Therefore  denudation 
methods had to be selected by their ability to keep this layer 
intact while removing the endothelium reliably at the same 
time. Previous static seeding experiments  used mechanic­
ally denuded HUV [4]. This method is not well suited for 
long vessels and turned out to be detrimental to the contract­
ile function. One particular feature of the vessel wall mor­
phology is the presence of a basal lamina which separates 
the single layer of endothelial cells from the smooth muscle 
layer.  This  layer  was  hypothesized  to  protect  the smooth 
muscle layer at least from some of the treatments required 
to remove the endothelial cells.
Fig 3: Comparison of denudation methods. Vessels were contracted with 
150 mM KCl. Values are reported relative to untreated vessels (** p<0.01, 
ANOVA)
Fig 4: Seeding of denHUV with HUVEC. (A) SEM image of native HUV 
luminal surface. (B) SEM image of  denHUV. (C) SEM image of seeded 
denHUV. (D) Fluorescence image of seeded denHUV cross section. 
Visible fluorescence indicates pre-labelled, seeded HUVEC.
Three denuding methods were identified and subjected to 
closer analysis. Enzymatic removal of endothelial cells is a 
common method to  isolate  and  cultivate  endothelial  cells 
from umbilical  veins and other  vessels.  Our data verified 
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standard conditions. However, the smooth muscle layer was 
affected as well by the digestion, as it showed both substan­
tial softening accompanied by structural damage and signi­
ficantly  reduced  contractile  function.  Preliminary  experi­
ments ruled out shorter incubation times as this would leave 
parts  of  the  endothelium  intact.  Enzymatic  denudation 
therefore is not suitable to obtain denHUV for tissue engin­
eering purposes.
Osmotic lysis turned out to be a highly effective method 
to  disrupt  and  remove endothelial  cells  without  inflicting 
visible  damage  to  the  smooth  muscle  layer.  Incubation 
times of 5 min in the presence of distilled water were suffi­
cient to remove the endothelum entirely. However, even in 
the absence of structural changes the smooth muscle layer 
was  affected  by  this  procedure.  Contractile  function  de­
clined at incubation times which were not sufficient to re­
move the endothelium completely.
Denuding by a stream of gas was originally developed to 
investigate a possible physiological role of the endothelium 
in microvessels. Although no mechanistic investigations are 
available, dehydration is likely to contribute a major part of 
the denuding action. After  empirical  optimization of flow 
rate and incubation time, this method appeared as a reliable 
and simple method to denude HUV. Moreover, contractile 
function was not affected at incubation times sufficient to 
remove the endothelium completely. Therefore this method 
was selected to prepare denHUV for seeding experiments.
Gelatin is a bovine product consisting mainly of hydro­
lyzed collagen. It  resembles the extracellular matrix suffi­
ciently to be used as a coating of cell culture flasks for en­
dothelial cell culture. As the condition of the extracellular 
matrix after denudation was not known beforehand, it was 
prudent to test the hypothesis that gelatin coating improves 
cell adhesion during seeding. Gelatin coating did not affect 
the  contractile  functions  of  both  HUV and denHUV and 
thus appeared safe to use.
The conditions required to obtain a uniform distribution 
of seeded endothelial cells on the luminal face of denHUV 
were arrived at empirically. Continuous rotation was not ne­
cessary.  Instead, a protocol was used which involved rota­
tion of the vessel for 90° and 180° in a fixed pattern to cov­
er the entire surface.  In  contrast  to seeding procedures of 
other scaffolds which may require static incubations ranging 
from 1 to 24 h [11], the first 30 min after infusing the cells 
appeared to be responsible for most if not all of the cell at­
tachment.  Uniform  distribution  was  ascertained  both  by 
cross sections investigated for the fluorescent signal of the 
UEA-labelled cells and by SEM images of the entire lumin­
al surface.  HUV denuded by dehydration and seeded at a 
density of 4.5E5 cells/cm2 regained a confluent and smooth 
endothelium using the described protocol. Coating denHUV 
with gelatin did not affect endothelial cell adhesion and was 
thus deemed unnecessary.
In conclusion, this study established a method to denude 
HUV without a loss of contractile function and without any 
noticeable limitation in vessel length. HUV denuded by this 
procedure is suitable for endothelial cell seeding in a perfu­
sion system and shows an excellent cell adhesion, resulting 
in a confluent and shear-resistant endothelium within 4 h of 
seeding.
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